Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 4.12622 | 67 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.90342 | 65 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.91941 | 65 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.82015 | 64 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.89872 | 65 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.26415 | 69 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 4.46423 | 71 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 4.04189 | 67 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.88189 | 65 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.84662 | 64 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.95389 | 66 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.8493 | 64 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 4.03729 | 67 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.96929 | 66 |